Compare BLZE & TECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLZE | TECX |
|---|---|---|
| Founded | 2007 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 762.0M | 618.9M |
| IPO Year | 2021 | 2018 |
| Metric | BLZE | TECX |
|---|---|---|
| Price | $12.73 | $23.33 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 9 |
| Target Price | $22.83 | ★ $76.63 |
| AVG Volume (30 Days) | ★ 1.5M | 233.3K |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 58.56 | 40.70 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $145,835,000.00 | N/A |
| Revenue This Year | $18.60 | N/A |
| Revenue Next Year | $25.89 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 14.27 | N/A |
| 52 Week Low | $3.26 | $15.45 |
| 52 Week High | $23.99 | $39.53 |
| Indicator | BLZE | TECX |
|---|---|---|
| Relative Strength Index (RSI) | 40.10 | 33.51 |
| Support Level | $12.48 | $20.52 |
| Resistance Level | $14.45 | $30.80 |
| Average True Range (ATR) | 0.69 | 1.39 |
| MACD | -0.00 | 0.11 |
| Stochastic Oscillator | 6.84 | 27.11 |
Backblaze Inc offers a cloud storage platform designed to help businesses and consumers store, use, and protect their data. The company delivers its services through the Backblaze Storage Cloud platform, a purpose-built, web-scale software architecture operating on commodity hardware. Backblaze's offerings include B2 Cloud Storage, an Infrastructure-as-a-Service (IaaS) solution, and Computer Backup, a Software-as-a-Service (SaaS) solution. Its customer base includes individuals, developers, MSPs, small and medium-sized businesses, and large enterprises across industries, academic institutions, government agencies, and other enterprises. Geographically, the company generates maximum revenue from its business in the United States, followed by the United Kingdom, Canada, and other markets.
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.